| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 152 |
| 1 | ALBUTEROL SULFATE | 97 |
| 2 | HYDROCHLOROTHIAZIDE | 85 |
| 3 | CLOPIDOGREL BISULFATE | 83 |
| 4 | RABEPRAZOLE | 83 |
| 5 | RISEDRONATE SODIUM | 80 |
| 6 | BUDESONIDE | 74 |
| 7 | ALBUTEROL | 56 |
| 8 | RABEPRAZOLE SODIUM | 52 |
| 9 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 50 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOGUANINE | 15 | 0.0071 |
| 1 | RISEDRONATE SODIUM | 80 | 0.0026 |
| 2 | CICLESONIDE | 33 | 0.0024 |
| 3 | RABEPRAZOLE SODIUM | 52 | 0.0019 |
| 4 | ACLIDINIUM BROMIDE | 11 | 0.0017 |
| 5 | RESLIZUMAB | 1 | 0.0015 |
| 6 | MERCAPTOPURINE | 17 | 0.0010 |
| 7 | CLOPIDOGREL BISULFATE | 83 | 0.0008 |
| 8 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 27 | 0.0007 |
| 9 | GLYCOPYRRONIUM | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 164 |
| 1 | Thiazide Diuretic [EPC] | 85 |
| 2 | Interleukin-5 Antagonist [EPC] | 57 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 35 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 33 |
| 5 | Purine Antimetabolite [EPC] | 31 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 23 |
| 7 | Provitamin D2 Compound [EPC] | 18 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 57 | 0.0828 |
| 1 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 2 | Thiazide Diuretic [EPC] | 85 | 0.0004 |
| 3 | Purine Antimetabolite [EPC] | 31 | 0.0003 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 33 | 0.0003 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 35 | 0.0003 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 23 | 0.0001 |
| 7 | Corticosteroid [EPC] | 164 | 0.0001 |
| 8 | Methylxanthine [EPC] | 6 | 0.0001 |
| 9 | Antirheumatic Agent [EPC] | 10 | 0.0001 |